Find therapies in clinical trials near you – page 824

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Study of Milademetan and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer with GATA3 Mutation, ER-Positive, HER2-Negative

Study of Milademetan and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer with GATA3 Mutation, ER-Positive, HER2-Negative

Study on Reversing Muscle Relaxation in Elderly Patients (75+) Using Sugammadex or Neostigmine/Glycopyrrolate During Laparoscopic Surgery

Study on Reversing Muscle Relaxation in Elderly Patients (75+) Using Sugammadex or Neostigmine/Glycopyrrolate During Laparoscopic Surgery

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Study of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis

Study of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis

Study on KTE-X19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma Responding Partially to Ibrutinib

Study on KTE-X19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma Responding Partially to Ibrutinib

Study on PRAX-628 for Epilepsy Patients with Light-Induced EEG Response

Study on PRAX-628 for Epilepsy Patients with Light-Induced EEG Response

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Continued Treatment Study for Adults with Advanced Cancer Using Pemigatinib

Continued Treatment Study for Adults with Advanced Cancer Using Pemigatinib